Rectosigmoid cancer is a cancer that starts where the rectum and sigmoid colon meet, and it most often affects older adults. Early symptoms of rectosigmoid cancer can include blood in the stool, a change in bowel habits, belly pain, or unexplained weight loss. Rectosigmoid cancer usually develops over time, and treatment often includes surgery, chemotherapy, radiation therapy, or a mix of these. Not everyone will have the same experience. Survival depends on how far rectosigmoid cancer has spread, but earlier treatment is linked with better outcomes.
How many people live with Rectosigmoid cancer?
Rectosigmoid cancer is usually counted within colon and rectal cancer rather than listed on its own; worldwide, about 5 million people were living with colorectal cancer within 5 years of diagnosis (Global Cancer Observatory, 2022), so if rectosigmoid tumors make up roughly 5% to 10% of these cancers, depending on exactly where the cancer is recorded as starting, that suggests about 250,000 to 500,000 people worldwide are living with rectosigmoid cancer, but this is an estimate rather than a direct count. In the United States, about 1.5 million people were living with colorectal cancer (American Cancer Society, 2022), which suggests roughly 75,000 to 150,000 people living with rectosigmoid cancer in the US by the same method, again as an estimate rather than a direct count.
Overview
Rectosigmoid cancerSymptoms
Rectosigmoid cancer can cause blood in the stool, belly pain, constipation, diarrhea, or a change in usual bowel habits. Many also feel tired or lose weight without trying. Early symptoms of rectosigmoid cancer can be mild at first.
Outlook and prognosis
Rectosigmoid cancer can often be treated successfully, especially when found early. Outlook depends mainly on the stage, whether surgery removes all visible cancer, and if it has spread to lymph nodes or distant organs. Follow-up care matters.
Causes and risk factors
Rectosigmoid cancer risk rises with older age, family history, inherited bowel-cancer syndromes, and long-standing inflammatory bowel disease. Smoking, heavy alcohol use, obesity, low activity, and diets high in red or processed meat can also raise risk.
Genetic influences
Genetics can matter in rectosigmoid cancer, but most cases are not caused by a single inherited change. Still, some people have a stronger family risk, so genetic counseling and testing may be recommended, especially with early-onset rectosigmoid cancer or several affected relatives.
Diagnosis
Rectosigmoid cancer is usually diagnosed after symptoms or screening lead to a colonoscopy with a biopsy. CT scans often help show the tumor's size and whether it has spread.
Treatment and drugs
Rectosigmoid cancer is often treated with surgery to remove the tumor and nearby lymph nodes. Many also need chemotherapy, and some receive radiation before surgery. Care depends on stage, spread, and overall health.
Symptoms
Rectosigmoid cancer can show up in everyday life as changes in bowel habits, blood in the stool, or a constant feeling that your bowels have not fully emptied. Early on, this might look like constipation one week, looser stools the next, or a small streak of blood on the toilet paper. The early symptoms of rectosigmoid cancer can be mild and easy to mistake for hemorrhoids, diet changes, or other common bowel problems. Some people have few symptoms until the cancer grows larger.
You may have constipation, diarrhea, or a pattern that switches back and forth over days or weeks. Some people with rectosigmoid cancer find they need the bathroom more often or feel their usual routine becomes unpredictable.
Blood may appear bright red on toilet paper or in the bowl, or it can make stool look darker than usual. Even small amounts of ongoing bleeding can matter if it keeps happening.
You may feel a sudden need to pass stool or feel like you still need to go right after a bowel movement. Sometimes very little comes out, but the urge keeps returning.
Many people describe a heavy, full, or blocked feeling low in the pelvis or rectum. This can come with straining or a constant sense that the bowel has not emptied fully.
How people usually first notice Rectosigmoid cancer?
Many people first notice rectosigmoid cancer through quiet changes in bathroom habits that do not go away, like new constipation, diarrhea, narrower stools, or the feeling that the bowel does not empty fully. Other early warning signs can include blood in the stool, belly cramping, bloating, fatigue, or unexplained weight loss, although some people have few symptoms at first and the cancer is only found during screening. Because these signs can also happen with common noncancerous conditions, the key clue is persistence or a clear change from your usual pattern, especially if it lasts more than a few weeks.
Types of Rectosigmoid cancer
Rectosigmoid cancer does not always behave in exactly the same way, because several types of rectosigmoid cancer can start from different kinds of cells. Symptoms don’t always look the same for everyone. Many living with rectosigmoid cancer have bowel changes, bleeding, or belly discomfort, but the pattern and pace can vary by tumor type.
Adenocarcinoma
This is by far the most common type, and it starts in the gland-like lining of the bowel. Many people notice blood in the stool, constipation, diarrhea, narrower stools, or a feeling that the bowel does not empty fully. Ongoing belly cramps, tiredness, and weight loss can appear as the cancer grows.
Mucinous type
This is a subtype of adenocarcinoma that makes large amounts of mucus. Some may notice more mucus mixed with the stool along with bleeding, bowel habit changes, or rectal pressure. It can sometimes spread in a different pattern and may be harder to treat than the usual form.
Signet ring type
This is a rare adenocarcinoma subtype that often grows more aggressively. Instead of causing early bleeding alone, it may lead to belly pain, blockage symptoms, rapid weight loss, or swelling as the bowel becomes narrowed. Early symptoms of rectosigmoid cancer from this type can be vague, which sometimes delays diagnosis.
Neuroendocrine tumor
This rarer type starts from hormone-related cells in the bowel wall. Small tumors may cause few symptoms at first, while larger ones can lead to bleeding, pain, bowel changes, or a mass sensation. Some release hormones, but that is uncommon in rectosigmoid tumors.
Rare other cancers
Less common cancers in this area include lymphoma, gastrointestinal stromal tumor, and very rare squamous cell cancers. These can still cause bleeding, pain, or bowel changes, but some are more likely to show up as a growing mass, blockage, or unexplained weight loss. The balance of symptoms can shift over time depending on how fast the tumor grows and where it sits.
Can I slow down the onset of symptoms?
Not in a proven way: once rectosigmoid cancer has started, there is no strong evidence that lifestyle changes can reliably delay when symptoms begin, but healthy habits are linked to a lower chance of developing this cancer in the first place. Research most strongly supports staying active, keeping a healthy weight, not smoking, limiting alcohol, and eating a diet with more fiber and fewer processed and red meats; these steps may reduce risk, but they do not guarantee prevention. The clearest medical step is regular colon cancer screening, which can find and remove precancer growths or catch cancer early, so while these steps cannot promise to prevent symptoms, they can still improve your chances.
What genetics can tell you about symptoms
Genetics can sometimes help explain why rectosigmoid cancer behaves differently from one person to another, including how fast it grows, how likely it is to spread, and in some cases which symptoms show up first. For example, inherited cancer conditions and changes in the tumor itself may be linked with an earlier age at diagnosis or a higher chance of certain patterns such as bleeding, bowel habit changes, anemia, or blockage, but symptoms still vary a lot from person to person. In everyday care, genetic testing is usually more useful for understanding risk, guiding treatment, and checking family risk than for precisely predicting exactly which symptoms someone will have.
Causes and risk factors
Rectosigmoid cancer often starts after cells in the lower bowel pick up DNA changes over many years. Age over 50, past colon or rectal polyps, and long-term inflammatory bowel disease can raise the risk. Some risks are modifiable (things you can change), others are non-modifiable (things you can’t). Family history and inherited gene changes, such as Lynch syndrome or familial adenomatous polyposis, also increase the chance of rectosigmoid cancer. Smoking, heavy alcohol use, extra body weight, low physical activity, and a diet high in processed or red meat and low in fiber are common risk factors for rectosigmoid cancer.
What are the most common causes or risk factors?
Rectosigmoid cancer usually does not have one single cause; it most often develops over time from changes in the cells where the lower colon meets the rectum, especially as people get older. The strongest risk factors are being age 50 or older, having colon or rectal cancer or growths called polyps in the past, a close family history of these cancers, inherited conditions such as Lynch syndrome, and long-term bowel inflammation, as can happen with ulcerative colitis or Crohn disease. Risk is also higher with smoking, heavy alcohol use, obesity, low physical activity, and a diet high in red or processed meat and low in fiber.
Environmental and biological risk factors
Rectosigmoid cancer becomes more likely when certain body-related conditions or outside exposures are present, although having a risk factor does not mean someone will develop cancer. Doctors often group risks into internal (biological) and external (environmental). The main risk factors for rectosigmoid cancer include older age, long-standing inflammatory bowel disease, a personal history of certain colon or rectal polyps or cancer, type 2 diabetes, prior radiation to the abdomen or pelvis, and male sex.
Most cases of rectosigmoid cancer happen after age 50, and the risk rises further with advancing age. This is one reason screening becomes more important as people get older.
Long-standing ulcerative colitis or Crohn's disease affecting the colon can keep the bowel lining inflamed for years. The longer and more extensive the inflammation, the higher the risk of rectosigmoid cancer can be.
A personal history of certain colon or rectal polyps means abnormal growths have already formed in the bowel lining. Some of these growths can turn into cancer over time if they are not found and removed.
If someone has already had colorectal cancer, the bowel has shown it can develop cancerous changes. That raises the chance of another tumor, including in the rectosigmoid area, so careful follow-up is usually advised.
Genetic risk factors
When rectosigmoid cancer runs in a family, it can raise practical questions about your own risk and whether relatives should be checked earlier. The main genetic risk factors are inherited changes that make polyps or cancers more likely to develop in the lower colon and rectum. Carrying a genetic change doesn’t guarantee the condition will appear. For many families, understanding the genetic risk factors for rectosigmoid cancer starts with looking for patterns such as several relatives with colorectal cancer, uterine cancer, or many colon polyps.
Family history: A close family history of colorectal cancer or advanced colon polyps can point to inherited risk, even when no single gene change is found. Risk is usually higher if a parent, brother, sister, or child was diagnosed at a younger age or if several relatives were affected.
Lynch syndrome: This inherited condition greatly raises the chance of rectosigmoid cancer and often leads to cancer earlier than usual. It happens when a gene that normally fixes DNA errors does not work properly.
FAP: Familial adenomatous polyposis, or FAP, causes many polyps to grow in the colon and rectum, often starting in the teen years or early adulthood. Without close follow-up and treatment, the chance of rectosigmoid cancer becomes very high.
MUTYH polyposis: This inherited syndrome often leads to multiple colon polyps and a higher colorectal cancer risk. The risk is strongest when someone inherits a changed MUTYH gene from both parents.
Peutz-Jeghers: This rare inherited syndrome can cause certain polyps throughout the digestive tract and increases the lifetime risk of several cancers, including colorectal cancer. Some people also have dark freckle-like spots around the lips or inside the mouth, especially earlier in life.
Juvenile polyposis: This inherited condition causes multiple noncancerous polyps in the digestive tract and can raise the risk of colon and rectal cancers. The level of risk varies from family to family, and some people develop many polyps while others develop fewer.
Lifestyle risk factors
Several everyday habits can influence the chance of developing rectosigmoid cancer. The strongest lifestyle-related links involve tobacco, alcohol, body weight, physical inactivity, and long-term eating patterns. When people ask about lifestyle risk factors for rectosigmoid cancer, the main concern is how these habits affect inflammation, insulin signaling, and exposure of the bowel lining to potentially harmful compounds.
Tobacco use raises the risk of cancers in the colon and rectum, including the rectosigmoid area. The risk tends to increase with heavier or longer-term smoking.
Regular alcohol intake, especially at higher amounts, is linked to a greater risk of rectosigmoid cancer. Risk generally rises as drinking increases over time.
Too little physical activity is associated with a higher risk of colorectal cancers. Regular exercise may help lower risk by improving insulin sensitivity, reducing inflammation, and supporting healthier bowel function.
Overweight and obesity are linked to a higher risk of rectosigmoid cancer. This may relate to chronic inflammation, altered hormone levels, and insulin resistance.
Risk prevention
Rectosigmoid cancer risk can often be lowered, even though it cannot always be fully prevented. The most effective step for many people is colorectal screening, because it can find and remove growths before they turn into cancer. Prevention is about lowering risk, not eliminating it completely.
Regular colorectal screening can lower the risk of rectosigmoid cancer by finding polyps before they become cancerous. Colonoscopy is especially helpful because it can both detect and remove these growths during the same test.
A strong family history of colorectal cancer or certain inherited conditions can raise the risk of rectosigmoid cancer. If this applies to you, talk to your doctor about how to prevent rectosigmoid cancer with earlier or more frequent screening, and whether genetic counseling may help.
Regular physical activity is linked to a lower risk of rectosigmoid cancer. For many, this can mean brisk walking, cycling, or other movement most days of the week.
Keeping weight in a healthy range may help reduce the risk of rectosigmoid cancer. Extra body fat, especially around the waist, is linked with higher colorectal cancer risk over time.
Can you prevent Rectosigmoid cancer?
You cannot fully prevent rectosigmoid cancer, but you can often lower the risk. The most proven steps are keeping up with colon and rectal cancer screening, which can find and remove small growths before they turn into cancer, and lowering well-known risks such as smoking, heavy alcohol use, low activity, extra body weight, and a diet high in processed or red meat.
Transmission
Rectosigmoid cancer is not infectious, so you cannot catch it from someone else through touch, sex, kissing, sharing food, or living in the same home. It does not spread between people the way a virus or bacterial infection can.
What can run in families is risk, not the cancer itself: some people inherit gene changes that make rectosigmoid cancer more likely, while many others develop it without a clear inherited cause. If you are wondering how rectosigmoid cancer is inherited, doctors usually mean these inherited risk genes and family patterns, not person-to-person spread.
When to test your genes
Consider genetic testing if rectosigmoid cancer is diagnosed at a young age, if you have relatives with colorectal, uterine, or related cancers, or if someone has had more than one cancer. Tumor testing can also guide treatment, and inherited testing may uncover Lynch syndrome, which can shape screening for you and your family.
Diagnosis
Rectosigmoid cancer is usually diagnosed after symptoms such as bleeding from the rectum, a change in bowel habits, belly pain, or unexplained weight loss lead to medical evaluation, although some cases are found during routine screening. It’s natural to worry when symptoms don’t have a clear explanation. The diagnosis of rectosigmoid cancer often combines a physical exam, a look inside the colon and rectum, imaging scans, and a lab check of tissue removed during testing.
Doctors usually begin by asking about symptoms, how long they have been happening, and whether there is a personal or family history of colon polyps, colorectal cancer, or bowel disease. This helps guide which tests are most useful and how urgent they may be.
A clinician may examine the abdomen for tenderness, swelling, or a mass and may do a rectal exam to check for blood or a tumor low in the rectum. These findings cannot confirm rectosigmoid cancer on their own, but they can raise concern and help plan next steps.
This test uses a thin, flexible tube with a camera to look at the inside of the colon and rectum and is often the key step in how rectosigmoid cancer is diagnosed. If doctors see an abnormal area, they can usually take a small tissue sample during the same procedure.
A pathologist examines the tissue sample under a microscope to confirm whether cancer cells are present. This is the test that makes the diagnosis and can also give important details about the type of tumor.
How is Rectosigmoid cancer diagnosed?
Rectosigmoid cancer is usually diagnosed with a colonoscopy, a test that lets the doctor look inside the lower part of the large bowel with a thin, flexible camera and take a small tissue sample. The diagnosis is confirmed when that sample is checked under a microscope and cancer cells are found. After that, scans such as CT or MRI are often used to see the exact size of the cancer and whether it has spread, and sometimes the tumor or a blood sample is also checked for gene changes to help plan treatment.
Stages of Rectosigmoid cancer
Rectosigmoid cancer is usually described by how far it has grown into the bowel wall and whether it has spread, rather than by day-to-day symptom changes alone. This staging helps doctors plan treatment and talk through outlook in a clear way. Often the process begins when you notice changes in daily life, such as bleeding, a lasting change in bowel habits, or other early symptoms of rectosigmoid cancer.
Stage 0
Abnormal cells are only in the inner lining of the bowel and have not grown deeper. This is the earliest stage and is sometimes called cancer in situ.
Stage I
The cancer has grown into the wall of the rectosigmoid area but has not reached nearby lymph nodes or distant organs. Many people have no symptoms at this stage, or only mild bowel changes.
Stage II
The cancer has grown more deeply through the bowel wall and may reach nearby tissues, but it still has not spread to lymph nodes. Treatment often depends on how far through the wall the tumor has grown.
Stage III
The cancer has spread to nearby lymph nodes but not to distant parts of the body. Even if the main tumor seems limited, lymph node spread makes this a more advanced stage.
Stage IV
The cancer has spread to distant organs such as the liver, lungs, or lining of the abdomen. Symptoms can vary widely depending on where the cancer has spread.
Outlook and prognosis
The outlook for rectosigmoid cancer depends mainly on the stage at diagnosis, tumor biology, and whether it can be completely removed and treated effectively. When found at an early, localized stage, outcomes are often favorable, with high chances of long-term survival after surgery, often combined with chemotherapy and sometimes radiation depending on the exact location and extent. Prognosis becomes less favorable when lymph nodes are involved or when the cancer has spread to distant organs such as the liver or lungs, although modern systemic therapies and metastasis-directed treatments can still prolong survival for some patients. Mortality is highest in advanced metastatic disease, while early-stage disease has substantially lower cancer-related death rates. Other factors that influence prognosis include the patient’s age, overall health, response to treatment, and molecular features of the tumor. Regular follow-up after treatment is important because recurrence risk is greatest in the first few years, and early detection of recurrence can improve management options.
Long-term effects
Rectosigmoid cancer can affect long-term health in different ways, depending on the stage at diagnosis, the treatments used, and whether the cancer comes back. For many, this can mean changes in bowel habits, energy, and day-to-day comfort long after treatment ends. Thinking about the long-term effects helps set realistic expectations and makes follow-up care easier to understand. Even when treatment works well, some people live with lasting effects from surgery, chemotherapy, radiation, or the cancer itself.
Many people with rectosigmoid cancer have ongoing changes in how often they pass stool, along with diarrhea, constipation, urgency, or trouble fully emptying the bowel. This can make daily routines less predictable, such as needing to know where the nearest bathroom is when leaving home.
If treatment includes a colostomy or ileostomy, living with a stoma can be a long-term part of life. Over time, many discover ways to manage skin care, pouch changes, gas, and leaks, but the adjustment can still affect comfort, clothing choices, and confidence.
Surgery and radiation can leave some people with ongoing pelvic or abdominal pain, tenderness, or tight scar tissue. In some, internal scarring can also contribute to bowel blockage symptoms, which may need urgent medical care.
Rectosigmoid cancer treatment can affect nerves and tissues involved in sexual function. Some may find there are long-term problems with erections, vaginal dryness, pain with sex, or lower sexual interest, especially after pelvic surgery or radiation.
How is it to live with Rectosigmoid cancer?
Living with rectosigmoid cancer can change the rhythm of everyday life in very practical ways: many people deal with bowel changes such as urgency, constipation, diarrhea, abdominal discomfort, fatigue, and the emotional strain of tests, treatments, and uncertainty. Daily routines may need more planning around bathroom access, meals, work, appointments, and recovery time, especially during surgery, chemotherapy, or radiation. The effects often reach beyond the person with cancer, too, as family and friends may take on caregiving, transportation, finances, and emotional support, but with good medical care, clear communication, and help from a support network, many people find ways to adapt and keep a sense of control.
Treatment and drugs
Treatment for rectosigmoid cancer usually depends on how far the cancer has grown, where it sits between the rectum and sigmoid colon, and your overall health. Many people with rectosigmoid cancer are treated with surgery to remove the tumor, and some also need chemotherapy, radiation therapy, or both before or after surgery to lower the chance of the cancer coming back. Treatment plans often combine several approaches. If rectosigmoid cancer has spread, treatment may focus on slowing the disease, easing symptoms, and helping you stay as active and comfortable as possible, sometimes with targeted drugs or immunotherapy if the tumor has certain features. Finding the right therapy can take some time, and your care team will often tailor treatment to balance cancer control with day-to-day issues like bowel function, pain, energy, and recovery after treatment.
Can you cure Rectosigmoid cancer?
Rectosigmoid cancer can sometimes be cured, especially if it is found early and doctors can remove all of it with surgery. There is not one guaranteed cure for everyone, and if the cancer has spread or cannot be fully removed, treatment usually focuses on shrinking it, slowing it down, easing symptoms, and helping people live longer; this may include surgery, chemotherapy, radiation, or other cancer medicines. The chances of cure depend mostly on how far the cancer has grown and a person’s overall health.
Non-drug treatment
Treatment for rectosigmoid cancer often involves more than medicines, and day to day this can affect eating, bowel habits, energy, and recovery after procedures. For many, treatment begins not at the pharmacy, but with surgery and other targeted therapies aimed at removing or shrinking the tumor. The best plan depends on the stage of rectosigmoid cancer, where the tumor sits, and your overall health. If you are looking into treatment after the early symptoms of rectosigmoid cancer led to testing, it helps to know that several non-drug options may be used together.
Surgery is the main non-drug treatment for many people with rectosigmoid cancer. The goal is to remove the tumor and nearby lymph nodes, and sometimes reconnect the bowel in the same operation. In some cases, a temporary or permanent ostomy is needed so stool can leave the body safely.
Radiation uses focused high-energy beams to damage cancer cells in a specific area. It is used more often when the tumor is closer to the rectum, either before surgery to shrink it or after surgery in selected cases.
Some small or blocked tumors can be managed with procedures such as endoscopic removal or a stent to open the bowel. These approaches are not right for everyone, but they can help relieve symptoms or treat very early disease in selected people.
Eating can become harder because of pain, blockage, weight loss, or changes after surgery. A dietitian can help you get enough calories, protein, and fluids, and can suggest ways to manage diarrhea, constipation, or an ostomy.
Your genes may have an impact on how drugs work for you
For people with rectosigmoid cancer, small inherited differences in the body can change how some common chemotherapy medicines are broken down, which can raise the chance of serious side effects or mean a lower dose is safer. Changes inside the cancer itself can also matter, because they may show whether certain targeted treatments are likely to help or are unlikely to work. This kind of gene-guided treatment planning is part of what is called pharmacogenomics, and for many living with rectosigmoid cancer, it can help doctors choose medicines more safely and more effectively.
Pharmacological treatments
Drug treatment for rectosigmoid cancer often depends on the stage of the cancer, whether surgery is planned, and whether the cancer has spread. Many living with rectosigmoid cancer receive chemotherapy, targeted therapy, immunotherapy, or a combination of these. Not everyone responds to the same medication in the same way, so treatment is often tailored using tumor test results such as RAS, BRAF, HER2, or mismatch repair status.
These are common backbone drugs for rectosigmoid cancer and are often used before or after surgery, or for cancer that has spread. 5-fluorouracil, often called 5-FU, is usually given by vein, while capecitabine is a tablet that turns into 5-FU in the body.
Oxaliplatin is often combined with 5-FU or capecitabine in regimens such as FOLFOX or CAPOX. These combinations are widely used as first treatment because they can shrink tumors and lower the risk of the cancer coming back after surgery.
Irinotecan is another key chemotherapy drug, often used in FOLFIRI or in stronger combinations such as FOLFOXIRI for some people with advanced disease. It may be chosen when cancer grows after earlier treatment or when a faster, deeper response is needed.
Bevacizumab, ramucirumab, and aflibercept are targeted drugs that block blood vessel growth to the tumor. They are usually given with chemotherapy for advanced rectosigmoid cancer, especially when the tumor does not have a target that points to another treatment.
Genetic influences
Rectosigmoid cancer can sometimes be linked to inherited risk, especially if it develops at a younger age or shows up in several close relatives. It’s natural to ask whether family history plays a role. Most people with rectosigmoid cancer do not have one single inherited gene change causing it, but some families carry conditions such as Lynch syndrome or familial adenomatous polyposis, which can greatly raise the chance of cancer in this part of the bowel.
If you have a strong family history of rectosigmoid cancer or related cancers, genetic counseling and testing may help clarify whether an inherited risk is present. Even when genes are part of the picture, they do not tell the whole story, and regular screening can still help find rectosigmoid cancer or precancerous growths early.
Is Rectosigmoid cancer genetic?
Genetics can matter in rectosigmoid cancer, but most cases are not caused by a single inherited change. Still, some people have a stronger family risk, so genetic counseling and testing may be recommended, especially with early-onset rectosigmoid cancer or several affected relatives.
Having a genetic risk is not necessarily a diagnosis
Differences in genes are a normal part of human biology and are widespread in the general population. Most of these variants do not have a direct effect on health and are simply part of natural human diversity. For many genes, having a variant associated with a condition suggests a possible link rather than a definite diagnosis, especially when several genes and environmental factors are involved. In some situations, however, a single well-studied variant in a particular gene can be enough to confirm a diagnosis.
Pharmacogenetics—how genetics influence drug effects
Treatment for rectosigmoid cancer is often tailored to the genetic changes found in the tumor, because those changes can show which medicines are more or less likely to help. In genetic testing for rectosigmoid cancer treatment, doctors may look for changes such as KRAS, NRAS, or BRAF, and for signs that the tumor has trouble repairing DNA; these results can guide the use of targeted drugs or immunotherapy. For example, if a tumor has certain KRAS or NRAS changes, some targeted medicines are unlikely to work, while tumors with mismatch repair deficiency or MSI-high features may respond better to immunotherapy. Genetic testing can sometimes identify how your body may handle common chemotherapy drugs too, because inherited differences such as DPYD or UGT1A1 can raise the risk of serious side effects from 5-FU, capecitabine, or irinotecan. Many living with rectosigmoid cancer find that this kind of testing helps their care team choose safer doses or different treatments. Genetics is only one factor, so doctors also consider the cancer stage, overall health, and how the cancer has responded so far.
Interactions with other conditions
People living with rectosigmoid cancer may also be dealing with other health problems, and that can affect symptoms, treatment choices, and recovery. Bowel diseases such as diverticulitis or inflammatory bowel disease can sometimes cause pain, bleeding, or changes in bowel habits that overlap with early symptoms of rectosigmoid cancer, which can make the picture less clear at first. Doctors call it a comorbidity when two conditions occur together. Diabetes, heart disease, kidney disease, or lung disease may raise the risks linked to surgery, chemotherapy, or radiation, and infections or poor nutrition can make it harder for the body to heal. Some may find that anemia, blood clots, or liver disease become especially important because rectosigmoid cancer itself can affect blood loss, appetite, and how well the body handles medicines. When rectosigmoid cancer spreads, it most often affects nearby lymph nodes, the liver, or the lungs, and those changes can interact with existing illness in ways that need close, coordinated care.
How genes can cause diseases
Humans have more than 20,000 genes, each carrying out one or a few specific functions in the body. One gene instructs the body to digest lactose from milk, another tells the body how to build strong bones and another prevents the body's cells from beginning to multiply uncontrollably and developing into cancer. As all of these genes combined are the building instructions for our body, a defect in one of these genes can have severe health consequences.
Through decades of genetic research, we know the genetic code of any healthy/functional human gene. We have also identified that in certain positions on a gene, some individuals may have a different genetic letter from the one you have. We call these hotspots "Genetic Variations" or "Variants" in short. In many cases, studies have been able to show that having the genetic letter "G" in the position makes you healthy, but having the letter "A" in the same position disrupts the gene function and causes a disease. Genopedia allows you to view these variants in genes and summarizes all that we know from scientific research, which genetic letters (Genotype) have good or bad consequences on your health or on your traits.
What other conditions can cause similar symptoms to Rectosigmoid cancer?
Other conditions that can cause symptoms like rectosigmoid cancer include hemorrhoids, diverticulitis, inflammatory bowel disease, irritable bowel syndrome, bowel infections, and noncancerous growths such as colon polyps. These can also lead to blood in the stool, belly pain, changes in bowel habits, or a feeling that the bowel does not empty fully. Because the symptoms can overlap so much, doctors often need tests to tell the difference.
History
Changes in bowel habits, cramping, or blood in the stool are the kinds of problems that have pushed people to seek help for centuries. What we now call rectosigmoid cancer, a cancer arising where the lower colon meets the rectum, was not clearly separated from other bowel diseases for much of medical history, because doctors had few ways to see inside the body and symptoms often overlapped with hemorrhoids, infections, or inflammatory conditions.
Since the earliest days of medicine, efforts have been made to understand illnesses that caused blockage, bleeding, weight loss, and worsening abdominal pain. In the 1800s, as surgery, anesthesia, and pathology improved, doctors became better at recognizing tumors in the lower bowel and describing where they started. That mattered in everyday life: someone who had months of constipation, narrow stools, or pain with bowel movements could finally be told more clearly what was happening, even though treatment options were still limited and often risky.
In the 20th century, rectosigmoid cancer care changed quickly. Rigid scopes, and later flexible sigmoidoscopy and colonoscopy, allowed doctors to look directly at the lining of the bowel, take samples, and find some cancers earlier. Imaging tests, safer operations, radiation for cancers closer to the rectum, and chemotherapy all improved outcomes. Over time, doctors also learned that cancers in this area can behave a little differently depending on their exact location, which helped guide treatment planning.
More recently, screening programs and growing public awareness have made a major difference in both the United States and Europe. Many living with rectosigmoid cancer are now diagnosed earlier than in the past, sometimes before symptoms become severe, and researchers have also identified general genetic and biological changes that help explain why these tumors develop. Looking back helps explain why paying attention to early symptoms of rectosigmoid cancer, especially ongoing bleeding or a lasting change in bowel habits, remains such an important part of care today.